A recent study funded by the National Institutes of Health found that clomiphene therapy led to more live births than letrozole for couples experiencing unexplained infertility. The study involved 900 couples, and the results were published in the New England Journal of Medicine.

New analysis allows healthcare providers to more accurately prescribe medications.

The U.S. Preventive Services Task Force (USPSTF) released its final recommendation statement on screening for hypertension in adults on Oct. 13. As the age of the U.S. population has risen, so has the prevalence of high blood pressure. Researchers from USPSTF found that screening patients over the age of 18 for hypertension can have a significant and positive effect on health outcomes.

A recent study funded by the National Institutes for Health (NIH) showed that treating low blood glucose - more commonly known as hypoglycemia - in newborns according to the recommendations already in place has proven to be safe and to apparently prevent brain damage. The study's findings were published Thursday in the New England Journal of Medicine.

Government price controls on pharmaceuticals won't solve current issues facing industry.

Issues are related to identity proofing documentation and verification of eligibility.

Officials of the American Medical Association (AMA) and the Medical Group Management Association (MGMA) announced the top five proposals they selected from submissions to their joint Practice Innovation Challenge on Oct. 12. "This partnership with AMA highlights the capabilities of MGMA's most innovative members," MGMA President and CEO Halee Fischer-Wright said.

U.S. Department of Health and Human Services (HHS) officials said Thursday their goal is to sign up at least 1 of every 4 uninsured consumers who are eligible for health care coverage.HHS Secretary Sylvia Burwell said by the end of 2016, she expects 10 million American's to be enrolled - and paying their premiums - in coverage through a Health Insurance Marketplace.

The wave of nonprofit health insurance exchanges, or co-ops, created under the Affordable Care Act to foster competition appears to be lessening to a ripple. One academic said she understands why these state co-ops are struggling. “It is difficult to achieve the scale needed to effectively negotiate with providers,” Wharton School Assistant Professor Amanda Starc told Patient Daily.

Robert Nelsen: Price controls will reduce innovation and increase costs over the long-run.

Attempts to quit using cigarettes by adults in the U.S. stalled between 2011 and 2013, according to a report that was released on Oct. 15 by the Centers for Disease Control and Prevention (CDC), but a national nonprofit says that there are ways to reverse that trend.

Money will go toward improving hospital care in Minnesota and Texas

Biology is highly unpredictable, making innovative American drug development costly. Thus, what patients pay in unregulated prices for their medicines is necessary to fund the discovery of what could become the next notable and desired remedy, Dr. Thomas Stossel of Harvard Medical School told Patient Daily. The money to fund such endeavors has to come from somewhere, he said.

Areas discussed included antisense oligonucleotides, gene therapy and stem cell therapy as well as trial development, model systems and biomarker discovery.

The panel was sponsored by the ERISA Industry Committee.

Statistics from the Centers for Disease Control indicate that nearly 2 million Americans abuse prescription pain medications.

Those with Type 2 diabetes were shown to have higher lactate levels.

Dr. Emil Kakkis and others take out full-page ad in New York Times.

Study highlighted the effect of anti-hepatitis C, HIV, anti-hypertensives and anti-inflammatories on fetuses.

Dr. Otis Webb Brawley elected to serve with 2015 Class of the National Academy of Medicine